ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
JAMA Reports Fluvoxamine as Potential Early Treatment for COVID-19
November 13, 2020The COVID-19 Early Treatment Fund (CETF), announced that JAMA, The Journal of the American Medical Association, published the results of a Washington University School of Medicine in St. Louis double-blind, randomized controlled clinical trial that ... -
Trial supports use of fluvoxamine in patients with mild COVID-19
October 16, 2020A clinical trial has demonstrated that the likelihood of hospitalisation was significantly reduced for patients with mild COVID-19 when given fluvoxamine.
Pharma Sources Insight January 2025
